Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice

G. Haskó, Csaba Szabo, K. Merkel, A. Bencsics, B. Zingarelli, V. Kvetan, E. S. Vizi

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The effects of various agonists and antagonists of dopamine D1 and D2 receptors on lipopolysaccharide (LPS)-induced tumor necrosis factor-α (TNF-α) and nitric oxide (NO) production was investigated in mice. Pretreatment of animals with bromocryptine or quinpirole, agonists of dopamine D2 receptors caused a blunting of both the TNF-α and MO responses to LPS injected intraperitoneally. Sulpiride, an antagonist of dopamine D2 receptors, decreased the LPS-induced TNF-α plasma levels in a dose-dependent manner and inhibited the LPS-induced NO production by peritoneal macrophages. Bromocryptine or quinpirole blunted both the TNF-α and NO response to LPS. SCH-23390, an antagonist of dopamine D1 receptors did not alter LPS-induced TNF-α production, but inhibited LPS-induced NO production. These results indicate that while the D2 subtype of dopamine receptors is involved in the modulation of both LPS-induced TNF-α and NO production, dopamine D1 receptors only regulate the production of NO. Since several drugs possess effect on dopamine D2 receptors, the present observations may be of clinical relevance.

Original languageEnglish (US)
Pages (from-to)143-147
Number of pages5
JournalImmunology Letters
Volume49
Issue number3
DOIs
StatePublished - Mar 1996
Externally publishedYes

Fingerprint

Dopamine Antagonists
Dopamine Agonists
Lipopolysaccharides
Nitric Oxide
Tumor Necrosis Factor-alpha
Dopamine D2 Receptors
Dopamine D1 Receptors
Quinpirole
Bromocriptine
Sulpiride
Peritoneal Macrophages
Pharmaceutical Preparations

Keywords

  • Bromocryptine
  • Dopamine D receptors
  • Dopamine D receptors
  • Lipopolysaccharide-induced tumor necrosis factor-α
  • SCH-23390
  • Sulpiride

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice. / Haskó, G.; Szabo, Csaba; Merkel, K.; Bencsics, A.; Zingarelli, B.; Kvetan, V.; Vizi, E. S.

In: Immunology Letters, Vol. 49, No. 3, 03.1996, p. 143-147.

Research output: Contribution to journalArticle

Haskó, G. ; Szabo, Csaba ; Merkel, K. ; Bencsics, A. ; Zingarelli, B. ; Kvetan, V. ; Vizi, E. S. / Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice. In: Immunology Letters. 1996 ; Vol. 49, No. 3. pp. 143-147.
@article{dda89511842042149bf8882d1a8ea354,
title = "Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice",
abstract = "The effects of various agonists and antagonists of dopamine D1 and D2 receptors on lipopolysaccharide (LPS)-induced tumor necrosis factor-α (TNF-α) and nitric oxide (NO) production was investigated in mice. Pretreatment of animals with bromocryptine or quinpirole, agonists of dopamine D2 receptors caused a blunting of both the TNF-α and MO responses to LPS injected intraperitoneally. Sulpiride, an antagonist of dopamine D2 receptors, decreased the LPS-induced TNF-α plasma levels in a dose-dependent manner and inhibited the LPS-induced NO production by peritoneal macrophages. Bromocryptine or quinpirole blunted both the TNF-α and NO response to LPS. SCH-23390, an antagonist of dopamine D1 receptors did not alter LPS-induced TNF-α production, but inhibited LPS-induced NO production. These results indicate that while the D2 subtype of dopamine receptors is involved in the modulation of both LPS-induced TNF-α and NO production, dopamine D1 receptors only regulate the production of NO. Since several drugs possess effect on dopamine D2 receptors, the present observations may be of clinical relevance.",
keywords = "Bromocryptine, Dopamine D receptors, Dopamine D receptors, Lipopolysaccharide-induced tumor necrosis factor-α, SCH-23390, Sulpiride",
author = "G. Hask{\'o} and Csaba Szabo and K. Merkel and A. Bencsics and B. Zingarelli and V. Kvetan and Vizi, {E. S.}",
year = "1996",
month = "3",
doi = "10.1016/0165-2478(96)02494-7",
language = "English (US)",
volume = "49",
pages = "143--147",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice

AU - Haskó, G.

AU - Szabo, Csaba

AU - Merkel, K.

AU - Bencsics, A.

AU - Zingarelli, B.

AU - Kvetan, V.

AU - Vizi, E. S.

PY - 1996/3

Y1 - 1996/3

N2 - The effects of various agonists and antagonists of dopamine D1 and D2 receptors on lipopolysaccharide (LPS)-induced tumor necrosis factor-α (TNF-α) and nitric oxide (NO) production was investigated in mice. Pretreatment of animals with bromocryptine or quinpirole, agonists of dopamine D2 receptors caused a blunting of both the TNF-α and MO responses to LPS injected intraperitoneally. Sulpiride, an antagonist of dopamine D2 receptors, decreased the LPS-induced TNF-α plasma levels in a dose-dependent manner and inhibited the LPS-induced NO production by peritoneal macrophages. Bromocryptine or quinpirole blunted both the TNF-α and NO response to LPS. SCH-23390, an antagonist of dopamine D1 receptors did not alter LPS-induced TNF-α production, but inhibited LPS-induced NO production. These results indicate that while the D2 subtype of dopamine receptors is involved in the modulation of both LPS-induced TNF-α and NO production, dopamine D1 receptors only regulate the production of NO. Since several drugs possess effect on dopamine D2 receptors, the present observations may be of clinical relevance.

AB - The effects of various agonists and antagonists of dopamine D1 and D2 receptors on lipopolysaccharide (LPS)-induced tumor necrosis factor-α (TNF-α) and nitric oxide (NO) production was investigated in mice. Pretreatment of animals with bromocryptine or quinpirole, agonists of dopamine D2 receptors caused a blunting of both the TNF-α and MO responses to LPS injected intraperitoneally. Sulpiride, an antagonist of dopamine D2 receptors, decreased the LPS-induced TNF-α plasma levels in a dose-dependent manner and inhibited the LPS-induced NO production by peritoneal macrophages. Bromocryptine or quinpirole blunted both the TNF-α and NO response to LPS. SCH-23390, an antagonist of dopamine D1 receptors did not alter LPS-induced TNF-α production, but inhibited LPS-induced NO production. These results indicate that while the D2 subtype of dopamine receptors is involved in the modulation of both LPS-induced TNF-α and NO production, dopamine D1 receptors only regulate the production of NO. Since several drugs possess effect on dopamine D2 receptors, the present observations may be of clinical relevance.

KW - Bromocryptine

KW - Dopamine D receptors

KW - Dopamine D receptors

KW - Lipopolysaccharide-induced tumor necrosis factor-α

KW - SCH-23390

KW - Sulpiride

UR - http://www.scopus.com/inward/record.url?scp=0029968916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029968916&partnerID=8YFLogxK

U2 - 10.1016/0165-2478(96)02494-7

DO - 10.1016/0165-2478(96)02494-7

M3 - Article

C2 - 8739308

AN - SCOPUS:0029968916

VL - 49

SP - 143

EP - 147

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 3

ER -